Gilead Raday
Chief Operating Officer at REDHILL BIOPHARMA LTD.
Net worth: 112 137 $ as of 30/05/2024
Gilead Raday active positions
Companies | Position | Start | End |
---|---|---|---|
REDHILL BIOPHARMA LTD. | Chief Operating Officer | 31/03/2016 | - |
Corporate Officer/Principal | 09/11/2010 | 29/02/2016 |
Career history of Gilead Raday
Former positions of Gilead Raday
Companies | Position | Start | End |
---|---|---|---|
Sepal Pharma Plc
Sepal Pharma Plc Pharmaceuticals: MajorHealth Technology Sepal Pharma Plc is a British company that manufactures pharmaceutical preparations. | Chief Executive Officer | 31/12/2009 | 30/09/2010 |
Corporate Officer/Principal | 31/12/2008 | 30/11/2009 | |
Charles Street Securities Europe LLP
Charles Street Securities Europe LLP Investment ManagersFinance Charles Street Securities Europe LLP (Charles Street) is a private equity firm founded in 1984. The firm is headquartered in the London, United Kingdom. | Private Equity Investor | 31/12/2003 | 31/12/2007 |
Vaccine Research International Plc
Vaccine Research International Plc Miscellaneous Commercial ServicesCommercial Services Vaccine Research International Plc is a British company that focuses on conducting clinical trials to evaluate the effectiveness of vaccine SA75 in preventing staphylococcal infections in hospital patients and the wider community. | Director/Board Member | - | - |
Vidac Pharma Ltd.
Vidac Pharma Ltd. Pharmaceuticals: MajorHealth Technology Vidac Pharma Ltd. manufactures pharmaceutical products. It is a clinical stage biopharmaceutical company dedicated to discovering and developing first-in-class medicines to help people suffering from a range of oncologic and dermatologic diseases. The company was founded in 2011 by Max Herzberg is headquartered in Jerusalem, Israel. | Director/Board Member | - | - |
Celsus Therapeutics Plc
Celsus Therapeutics Plc Pharmaceuticals: MajorHealth Technology Celsus Therapeutics Plc is a drug development company, which focuses on developing novel, first-in-class, non-steroidal, synthetic anti-inflammatory drugs and multi-functional anti-inflammatory drugs. The company main clinical candidates are MRX-5, MRX-6, MRX-4, CFX-1 and OPX-1. Celsus Therapeutics was founded on October 7, 2004 and is headquartered in London, the United Kingdom. | Director/Board Member | 15/06/2005 | - |
Independent Dir/Board Member | 24/02/2013 | - | |
TK-Signal Ltd.
TK-Signal Ltd. Medical SpecialtiesHealth Technology TK-Signal Ltd. develops therapies for hematological cancer applications. Its product TKS040, which manage and trace focused drug therapy for cancer patients. The firm also develops various radiopharmaceutical molecular imaging tracers, specific molecular radiotherapy agents, and radioactive biomarkers to diagnose and monitor cancerous tumors. TK-Signal was founded in 2001 by Eyal Mishani and Alexander Levitzki and is headquartered in Jerusalem, Israel. | Director/Board Member | 17/02/2011 | - |
Training of Gilead Raday
The Hebrew University of Jerusalem | Graduate Degree |
University of Cambridge | Graduate Degree |
Statistics
International
United Kingdom | 6 |
Israel | 5 |
Operational
Director/Board Member | 4 |
Graduate Degree | 2 |
Corporate Officer/Principal | 2 |
Sectoral
Health Technology | 6 |
Consumer Services | 3 |
Finance | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
Listed companies | 1 |
---|---|
REDHILL BIOPHARMA LTD. | Health Technology |
Private companies | 6 |
---|---|
Charles Street Securities Europe LLP
Charles Street Securities Europe LLP Investment ManagersFinance Charles Street Securities Europe LLP (Charles Street) is a private equity firm founded in 1984. The firm is headquartered in the London, United Kingdom. | Finance |
TK-Signal Ltd.
TK-Signal Ltd. Medical SpecialtiesHealth Technology TK-Signal Ltd. develops therapies for hematological cancer applications. Its product TKS040, which manage and trace focused drug therapy for cancer patients. The firm also develops various radiopharmaceutical molecular imaging tracers, specific molecular radiotherapy agents, and radioactive biomarkers to diagnose and monitor cancerous tumors. TK-Signal was founded in 2001 by Eyal Mishani and Alexander Levitzki and is headquartered in Jerusalem, Israel. | Health Technology |
Celsus Therapeutics Plc
Celsus Therapeutics Plc Pharmaceuticals: MajorHealth Technology Celsus Therapeutics Plc is a drug development company, which focuses on developing novel, first-in-class, non-steroidal, synthetic anti-inflammatory drugs and multi-functional anti-inflammatory drugs. The company main clinical candidates are MRX-5, MRX-6, MRX-4, CFX-1 and OPX-1. Celsus Therapeutics was founded on October 7, 2004 and is headquartered in London, the United Kingdom. | Health Technology |
Vidac Pharma Ltd.
Vidac Pharma Ltd. Pharmaceuticals: MajorHealth Technology Vidac Pharma Ltd. manufactures pharmaceutical products. It is a clinical stage biopharmaceutical company dedicated to discovering and developing first-in-class medicines to help people suffering from a range of oncologic and dermatologic diseases. The company was founded in 2011 by Max Herzberg is headquartered in Jerusalem, Israel. | Health Technology |
Sepal Pharma Plc
Sepal Pharma Plc Pharmaceuticals: MajorHealth Technology Sepal Pharma Plc is a British company that manufactures pharmaceutical preparations. | Health Technology |
Vaccine Research International Plc
Vaccine Research International Plc Miscellaneous Commercial ServicesCommercial Services Vaccine Research International Plc is a British company that focuses on conducting clinical trials to evaluate the effectiveness of vaccine SA75 in preventing staphylococcal infections in hospital patients and the wider community. | Commercial Services |
- Stock Market
- Insiders
- Gilead Raday
- Experience